Clinical Domain Certificate

Muscle Health and Healthy Ageing

Sarcopenia, anabolic decline and physiological ageing

Age-related anabolic decline, sarcopenia, muscle preservation and the physiology of healthy ageing.

Coming soonDates to be announcedPricing to be announced

About this programme

An evidence-based certificate examining the biology of skeletal muscle across the lifespan, the determinants of anabolic decline, and how the current literature frames muscle preservation in ageing populations.

Learning objectives

  • Explain the biology of muscle protein synthesis and breakdown.
  • Assess sarcopenia using current diagnostic frameworks.
  • Critically evaluate evidence for interventions targeting muscle health.
  • Integrate exercise, nutrition and pharmacological evidence.
  • Discuss the limits of current evidence with patients.

Programme outline

  • Skeletal muscle physiology and protein turnover
  • Anabolic resistance and the ageing muscle
  • Sarcopenia: definitions, assessment, evidence
  • Nutrition, exercise and pharmacological strategies
  • Critical appraisal of emerging anabolic therapies
  • Functional outcomes and patient-centred measures

Format

Online modular learning, gateway module plus domain content, structured assessment.

Audience

Qualified healthcare practitioners interested in musculoskeletal ageing.

Prerequisites

Completion of Introduction to Peptides in Health and Disease, or equivalent.

Dates & pricing

Enrolment dates, fees and admissions criteria will be published in due course. To register interest, please use the enquiry form on the home page.

This programme is educational in nature and written for a United States audience. It does not promote, market or recommend any drug, biologic, device or dietary supplement, and it does not provide prescribing protocols. The U.S. regulatory status of individual peptides — including approval, investigational status, and eligibility for pharmacy compounding under Sections 503A/503B — is determined by the FDA and may change over time. Clinical decisions remain the responsibility of individual U.S.-licensed practitioners operating within their state scope of practice and applicable federal and state law. See our full regulatory disclaimer.